CA Patent

CA3005169A1 — Stabilized solid composition containing 2-{4-[n-(5,6-diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n-(methylsulfonyl)acetamide and d-mannitol

Assigned to Nippon Shinyaku Co Ltd · Expires 2017-06-15 · 9y expired

What this patent protects

Provided is a stabilized solid preparation of 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide. A solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin- 2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl) acetamide and D-mannitol hav…

USPTO Abstract

Provided is a stabilized solid preparation of 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide. A solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin- 2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl) acetamide and D-mannitol having a specific surface area of 1.0 m2/g or less.

Drugs covered by this patent

Patent Metadata

Patent number
CA3005169A1
Jurisdiction
CA
Classification
—
Expires
2017-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.